HemoBioTech, Inc. Chairman and CEO, Dr. Arthur Bollon, to Give Update Tomorrow in Dallas on the Company and Development of Its Artificial Blood Product, HemoTech

DALLAS--(BUSINESS WIRE)--HemoBioTech (OTCBB: HMBT.OB) announced that its Chairman and CEO, Arthur Bollon, Ph.D., will give a luncheon presentation tomorrow (Wednesday, Aug. 1st) at the Tower Club (www.towerclub.com), Thanksgiving Tower, 1601 Elm Street, 48th Floor, Dallas. Please call WaLisa Davenport Satcher at 972-455-8953 for further information.